Literature DB >> 17510759

Paradoxical constitutive behavioral sensitization to amphetamine in mice lacking 5-HT2A receptors.

Lucas Salomon1, Christophe Lanteri, Gérard Godeheu, Gérard Blanc, Jay Gingrich, Jean-Pol Tassin.   

Abstract

RATIONALE: Although locomotor response to d-amphetamine is considered as mediated by an increased release of dopamine in the ventral striatum, blockade of either alpha1b-adrenergic or 5-HT2A receptors almost completely inhibits d-amphetamine-induced locomotor response in mice. In agreement with this finding, mice lacking alpha1b-adrenergic receptors hardly respond to d-amphetamine. However, we show here that, paradoxically, mice lacking 5-HT2A receptors (5-HT2A-R KO) exhibit a twofold higher locomotor response to d-amphetamine than wild-type (WT) littermates.
OBJECTIVES: To explore why there is a discrepancy between pharmacological and genetic 5-HT2A receptor blockade.
MATERIALS AND METHODS: Locomotor response and behavioral sensitization to d-amphetamine were measured in presence of prazosin and/or SR46349B, alpha1b-adrenergic, and 5-HT2A receptor antagonists, respectively.
RESULTS: Repeating amphetamine injections still increases 5-HT2A-R KO mice locomotor response to d-amphetamine at a level similar to that of sensitized WT mice. SR46349B (1 mg/kg) has, as expected, no effect in 5-HT2A-R KO mice. One milligrams per kilogram of prazosin completely blocks d-amphetamine-induced locomotor response in 5-HT2A-R KO naïve animals but 3 mg/kg is necessary in sensitized 5-HT2A-R KO mice.
CONCLUSIONS: Because naïve 5-HT2A-R KO mice exhibit an increased cortical noradrenergic response to d-amphetamine, our data suggest that repeated d-amphetamine modifies noradrenergic transmission in 5-HT2A-R KO mice. Stimulation of specific 5-HT2A receptors would inhibit noradrenergic neurons. Dramatic decrease in SR46349B efficiency in sensitized WT mice indicates that a disruption of the regulating role of 5-HT2A receptors on noradrenergic transmission occurs during sensitization and thus represents the physiological basis of behavioral sensitization to d-amphetamine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17510759     DOI: 10.1007/s00213-007-0810-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  37 in total

1.  Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.

Authors:  Agnès Auclair; Gérard Blanc; Jacques Glowinski; Jean-Pol Tassin
Journal:  J Neurochem       Date:  2004-10       Impact factor: 5.372

2.  Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis.

Authors:  A J Lategan; M R Marien; F C Colpaert
Journal:  Brain Res       Date:  1990-07-16       Impact factor: 3.252

3.  Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors.

Authors:  W X Shi; C L Pun; X X Zhang; M D Jones; B S Bunney
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

4.  Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine.

Authors:  P F Von Voigtlander; K E Moore
Journal:  J Pharmacol Exp Ther       Date:  1973-03       Impact factor: 4.030

5.  Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat.

Authors:  A J Pijnenburg; W M Honig; J M Van Rossum
Journal:  Psychopharmacologia       Date:  1975

6.  A 5-hydroxytryptamine2 agonist augments gamma-aminobutyric acid and excitatory amino acid inputs to noradrenergic locus coeruleus neurons.

Authors:  C Chiang; G Aston-Jones
Journal:  Neuroscience       Date:  1993-05       Impact factor: 3.590

7.  5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.

Authors:  Grégory Porras; Vincenzo Di Matteo; Claudia Fracasso; Guillaume Lucas; Philippe De Deurwaerdère; Silvio Caccia; Ennio Esposito; Umberto Spampinato
Journal:  Neuropsychopharmacology       Date:  2002-03       Impact factor: 7.853

8.  Evidence for a selective brain noradrenergic involvement in the locomotor stimulant effects of amphetamine in the rat.

Authors:  S O Ogren; T Archer; C Johansson
Journal:  Neurosci Lett       Date:  1983-12-30       Impact factor: 3.046

9.  Effects of serotonin (5-hydroxytryptamine, 5-HT) reuptake inhibition plus 5-HT(2A) receptor antagonism on the firing activity of norepinephrine neurons.

Authors:  Steven T Szabo; Pierre Blier
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030

10.  Behavioural deficits induced by an electrolytic lesion of the rat ventral mesencephalic tegmentum are corrected by a superimposed lesion of the dorsal noradrenergic system.

Authors:  K Taghzouti; H Simon; D Hervé; G Blanc; J M Studler; J Glowinski; M LeMoal; J P Tassin
Journal:  Brain Res       Date:  1988-02-02       Impact factor: 3.252

View more
  4 in total

1.  Serotonin 5-HT(2A) Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases.

Authors:  Charles D Nichols
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-10-13

2.  Effects of tryptophan deficiency on prepulse inhibition of the acoustic startle in rats.

Authors:  Marco Bortolato; Roberto Frau; Marco Orrù; Maria Collu; Giampaolo Mereu; Manolo Carta; Fabio Fadda; Roberto Stancampiano
Journal:  Psychopharmacology (Berl)       Date:  2008-03-12       Impact factor: 4.530

3.  Involvement of cholinergic system in hyperactivity in dopamine-deficient mice.

Authors:  Yoko Hagino; Shinya Kasai; Masayo Fujita; Susumu Setogawa; Hiroshi Yamaura; Dai Yanagihara; Makoto Hashimoto; Kazuto Kobayashi; Herbert Y Meltzer; Kazutaka Ikeda
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

4.  Reduced Efficacy of d-Amphetamine and 3,4-Methylenedioxymethamphetamine in Inducing Hyperactivity in Mice Lacking the Postsynaptic Scaffolding Protein SHANK1.

Authors:  A Özge Sungur; Tobias M Redecker; Elena Andres; Wiebke Dürichen; Rainer K W Schwarting; Adriana Del Rey; Markus Wöhr
Journal:  Front Mol Neurosci       Date:  2018-11-16       Impact factor: 5.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.